Financial Partners Group (Tennessee)’s Biogen BIIB Stock Holding History

Financial Partners Group (Tennessee)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,788	Closed	-$347K	–	95
2024 Q3	$347K	Buy	1,788 +395	+28%	+$82.6K	0.13%	81
2024 Q2	$323K	Buy	1,393 +345	+33%	+$75K	0.13%	82
2024 Q1	$226K	Buy	+1,048	New	+$245K	0.09%	92
2023 Q1	–	Sell	-2,130	Closed	-$590K	–	74
2022 Q4	$590K	Buy	+2,130	New	+$602K	0.35%	52

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Financial Partners Group (Tennessee)'s BIIB Position: Q4 2024 in Review

Financial Partners Group (Tennessee) sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,788 shares — an estimated $347K sold.

Financial Partners Group (Tennessee) first reported a position in BIIB in Q4 2022 and held it in 4 quarters. The position peaked at $590K in Q4 2022. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

Financial Partners Group (Tennessee) reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
Financial Partners Group (Tennessee) sold 1,788 Biogen shares in Q4 2024, an estimated $347K.
Financial Partners Group (Tennessee) first reported a position in Biogen in Q4 2022 and held it in 4 quarters.
Financial Partners Group (Tennessee)'s Biogen position peaked at $590K in Q4 2022.
876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Financial Partners Group (Tennessee)'s 13F filing for Q4 2024, filed 21 Jan 2025.